Pictet Bank & Trust’s Medline Inc MDLN Stock Holding History

Pictet Bank & Trust’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.74M	Buy	94,900 +75,922	+400%	+$3.06M	4.01%	7
2026 Q1	$845K	Buy	+18,978	New	+$838K	1.11%	28

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Bank & Trust's MDLN Position: Q2 2026 in Review

Pictet Bank & Trust increased its Medline Inc (MDLN) stake by 400% in Q2 2026, buying an estimated $3.06M and bringing the position to 94,900 shares worth $3.74M. The position accounts for 4.01% of the portfolio, ranked #7.

Pictet Bank & Trust first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 232 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Pictet Bank & Trust held 94,900 shares of Medline Inc worth $3.74M as of Q2 2026.
Pictet Bank & Trust bought 75,922 Medline Inc shares in Q2 2026, an estimated $3.06M.
Medline Inc made up 4.01% of Pictet Bank & Trust's portfolio in Q2 2026, its #7 holding.
Pictet Bank & Trust first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
232 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Pictet Bank & Trust's 13F filing for Q2 2026, filed 24 Jul 2026.